Priming of alveolar macrophage respiratory burst by H(2)O(2) is prevented by phosphatidylcholine-specific phospholipase C inhibitor Tricyclodecan-9-yl-xanthate (D609).
Girón-Calle, Julio
Priming of alveolar macrophage respiratory burst by H(2)O(2) is prevented by phosphatidylcholine-specific phospholipase C inhibitor Tricyclodecan-9-yl-xanthate (D609). [electronic resource] - The Journal of pharmacology and experimental therapeutics Apr 2002 - 87-94 p. digital
Publication Type: Journal Article
0022-3565
10.1124/jpet.301.1.87 doi
Animals
Antioxidants--pharmacology
Bridged-Ring Compounds--pharmacology
Cells, Cultured
Cytochrome c Group--metabolism
Hydrogen Peroxide--antagonists & inhibitors
Indicators and Reagents
Macrophages, Alveolar--drug effects
Norbornanes
Oxidants--pharmacology
Phosphatidylcholines--metabolism
Phosphodiesterase Inhibitors--pharmacology
Rats
Respiratory Burst--drug effects
Thiocarbamates
Thiones--pharmacology
Type C Phospholipases--antagonists & inhibitors
Priming of alveolar macrophage respiratory burst by H(2)O(2) is prevented by phosphatidylcholine-specific phospholipase C inhibitor Tricyclodecan-9-yl-xanthate (D609). [electronic resource] - The Journal of pharmacology and experimental therapeutics Apr 2002 - 87-94 p. digital
Publication Type: Journal Article
0022-3565
10.1124/jpet.301.1.87 doi
Animals
Antioxidants--pharmacology
Bridged-Ring Compounds--pharmacology
Cells, Cultured
Cytochrome c Group--metabolism
Hydrogen Peroxide--antagonists & inhibitors
Indicators and Reagents
Macrophages, Alveolar--drug effects
Norbornanes
Oxidants--pharmacology
Phosphatidylcholines--metabolism
Phosphodiesterase Inhibitors--pharmacology
Rats
Respiratory Burst--drug effects
Thiocarbamates
Thiones--pharmacology
Type C Phospholipases--antagonists & inhibitors